Insider Selling: Axon Enterprise (NASDAQ:AXON) Director Sells 198 Shares of Stock

Axon Enterprise, Inc (NASDAQ:AXON) Director Erika Nardini sold 198 shares of Axon Enterprise stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total transaction of $100,302.84. Following the sale, the director directly owned 1,946 shares of the company’s stock, valued at $985,804.68. The trade was a 9.24% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Axon Enterprise Stock Performance

AXON traded up $1.84 on Wednesday, reaching $508.41. The company had a trading volume of 519,629 shares, compared to its average volume of 1,015,229. The stock has a market cap of $40.88 billion, a P/E ratio of 334.48, a P/E/G ratio of 10.45 and a beta of 1.46. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53. Axon Enterprise, Inc has a fifty-two week low of $396.41 and a fifty-two week high of $885.91. The company’s fifty day moving average is $526.65 and its 200 day moving average is $604.44.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.55. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The firm had revenue of $796.72 million during the quarter, compared to the consensus estimate of $755.29 million. During the same period last year, the business posted $2.08 earnings per share. The business’s revenue for the quarter was up 38.5% compared to the same quarter last year. As a group, analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of research reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a report on Monday, December 29th. Needham & Company LLC dropped their target price on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a report on Friday, February 20th. Citigroup reissued a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Piper Sandler decreased their price target on shares of Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 25th. Finally, Morgan Stanley lowered their price target on shares of Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $762.93.

Institutional Investors Weigh In On Axon Enterprise

A number of large investors have recently added to or reduced their stakes in the stock. Creative Financial Designs Inc. ADV acquired a new position in Axon Enterprise in the 4th quarter valued at $28,000. Stone House Investment Management LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth $29,000. New Millennium Group LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth $29,000. Sound Income Strategies LLC increased its position in shares of Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares during the period. Finally, Camelot Portfolios LLC bought a new position in shares of Axon Enterprise in the fourth quarter worth $30,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Analysts and coverage are highlighting Axon’s growing Software & Services business — Zacks reports Software & Services revenue rose nearly 40% in 2025, underscoring the shift to recurring subscription revenue that supports higher-margin, more predictable cash flows. Axon’s Software & Services Strength in Focus
• Positive Sentiment: Institutional interest and positive write-ups continue — coverage and fund commentary (e.g., Baron Capital mentions) emphasize Axon as a growth company in public safety tech, which can support demand for the shares from growth-oriented investors. What Makes Axon Enterprise a Lucrative Investment?
• Positive Sentiment: Local government equipment purchases continue to provide steady demand — recent reports show Decatur and Yavapai County approving funding for police tech/TASER deployments, which supports steady device and evidence-management adoption at the municipal level. These contract wins are incremental but validate ongoing municipal demand. Decatur City Council accepts $1.97M grant Yavapai County slated to approve $25K for Tasers
• Neutral Sentiment: Stock is being widely discussed in the press and by retail platforms (Zacks/Yahoo trending pieces), which can increase volatility but is not a directional catalyst by itself. Axon Is a Trending Stock
• Neutral Sentiment: Reported short-interest data in the feeds is unreliable (shows 0 shares / NaN changes), so there’s no clear short-squeeze or heavy short pressure signal from these entries; days-to-cover is effectively reported as 0.0 days (no actionable insight).
• Negative Sentiment: Insider selling — Director Erika Nardini sold 198 shares on March 17 (filed with the SEC). The sale size is small relative to her remaining holdings, but insider sales can be perceived negatively by some investors. SEC Form 4
• Negative Sentiment: Recent price weakness and skeptical coverage — Forbes and some market pieces are questioning whether Axon’s high-growth story has cooled after a multi-day pullback and a several-billion-dollar market-cap decline, which can pressure sentiment and attract short-term sellers. Is Axon Stock’s Growth Story Over?
• Negative Sentiment: Short-term market move: recent session coverage noted a decline in the stock (session close down ~1.3%), contributing to near-term negative momentum and higher volatility. Axon Stock Falls Amid Market Uptick

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.